Form 10QSB - Optional form for quarterly and transition reports of small business issuers:
SEC Accession No. 0000318306-07-000048
Filing Date
2007-08-14
Accepted
2007-08-14 16:49:24
Documents
8
Period of Report
2007-08-14

Document Format Files

Seq Description Document Type Size
1 FORM 10QSB a2007_2q-10q2.htm 10QSB 543144
2 AMENDMENT TO ORACLE AND AFFILIATES CONV NOTES ex_10-40.htm EX-10.40 23067
3 AMENDMENT TO SCO AND AFFILIATES CONV NOTES ex_10-41.htm EX-10.41 109360
4 NOTE PURCHASE AGREEMENT SOMANTA PHARMA ex_10-42.htm EX-10.42 86955
5 CERTIFICATION CEO ex_31-1.htm EX-31.1 17563
6 CERTIFICATION CFO ex_31-2.htm EX-31.2 17926
7 CERTIFICATION CEO ex_32-1.htm EX-32.1 6401
8 CERTIFICATION CFO ex_32-2.htm EX-32.2 5869
  Complete submission text file 0000318306-07-000048.txt   811908
Mailing Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
ACCESS PHARMACEUTICALS INC (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10QSB | Act: 34 | File No.: 001-15771 | Film No.: 071056159
SIC: 2834 Pharmaceutical Preparations